Literature DB >> 21347642

Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists.

Patrick A Randall1, Eric J Nunes, Simone L Janniere, Colin M Stopper, Andrew M Farrar, Thomas N Sager, Younis Baqi, Jörg Hockemeyer, Christa E Müller, John D Salamone.   

Abstract

RATIONALE: Adenosine A(2A) antagonists can reverse many of the behavioral effects of dopamine antagonists, including actions on instrumental behavior. However, little is known about the effects of selective adenosine antagonists on operant behavior when these drugs are administered alone.
OBJECTIVE: The present studies were undertaken to investigate the potential for rate-dependent stimulant effects of both selective and nonselective adenosine antagonists.
METHODS: Six drugs were tested: two nonselective adenosine antagonists (caffeine and theophylline), two adenosine A(1) antagonists (DPCPX and CPT), and two adenosine A(2A) antagonists (istradefylline (KW6002) and MSX-3). Two schedules of reinforcement were employed; a fixed interval 240-s (FI-240 sec) schedule was used to generate low baseline rates of responding and a fixed ratio 20 (FR20) schedule generated high rates.
RESULTS: Caffeine and theophylline produced rate-dependent effects on lever pressing, increasing responding on the FI-240 sec schedule but decreasing responding on the FR20 schedule. The A(2A) antagonists MSX-3 and istradefylline increased FI-240 sec lever pressing but did not suppress FR20 lever pressing in the dose range tested. In fact, there was a tendency for istradefylline to increase FR20 responding at a moderate dose. A(1) antagonists failed to increase lever pressing rate, but DPCPX decreased FR20 responding at higher doses.
CONCLUSIONS: These results suggest that adenosine A(2A) antagonists enhance operant response rates, but A(1) antagonists do not. The involvement of adenosine A(2A) receptors in regulating aspects of instrumental response output and behavioral activation may have implications for the treatment of effort-related psychiatric dysfunctions, such as psychomotor slowing and anergia in depression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347642      PMCID: PMC3522121          DOI: 10.1007/s00213-011-2198-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  80 in total

Review 1.  Rate-dependent effects of drugs: a review of the literature.

Authors:  D J Sanger; D E Blackman
Journal:  Pharmacol Biochem Behav       Date:  1976-01       Impact factor: 3.533

Review 2.  Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease.

Authors:  K Fuxe; L F Agnati; K Jacobsen; J Hillion; M Canals; M Torvinen; B Tinner-Staines; W Staines; D Rosin; A Terasmaa; P Popoli; G Leo; V Vergoni; C Lluis; F Ciruela; R Franco; S Ferré
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

3.  Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats.

Authors:  Keita Ishiwari; Lisa J Madson; Andrew M Farrar; Susana M Mingote; John P Valenta; Michael D DiGianvittorio; Lauren E Frank; Merce Correa; Jörg Hockemeyer; Christa Müller; John D Salamone
Journal:  Behav Brain Res       Date:  2006-12-21       Impact factor: 3.332

Review 4.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

5.  Modulation of short-term social memory in rats by adenosine A1 and A(2A) receptors.

Authors:  Rui D S Prediger; Reinaldo N Takahashi
Journal:  Neurosci Lett       Date:  2004-12-09       Impact factor: 3.046

6.  Amphetamine and operant behavior in rats: relationship between drug effect and control response rate.

Authors:  T G Heffner; R B Drawbaugh; M J Zigmond
Journal:  J Comp Physiol Psychol       Date:  1974-06

7.  Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.

Authors:  W Hauber; P Neuscheler; J Nagel; C E Müller
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

8.  Some effects of d-amphetamine, caffeine, nicotine and cocaine on schedule-controlled responding of the mouse.

Authors:  J R Glowa
Journal:  Neuropharmacology       Date:  1986-10       Impact factor: 5.250

9.  Amphetamine and the adenosine A(2A) antagonist KW-6002 enhance the effects of conditional temporal probability of a stimulus in rats.

Authors:  Martin O'Neill; Verity J Brown
Journal:  Behav Neurosci       Date:  2007-06       Impact factor: 1.912

10.  The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure.

Authors:  Allison M Mott; Eric J Nunes; Lyndsey E Collins; Russell G Port; Kelly S Sink; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2009-01-09       Impact factor: 4.530

View more
  16 in total

Review 1.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

Review 2.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

Review 3.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

4.  Effects of caffeine and its metabolite paraxanthine on intracranial self-stimulation in male rats.

Authors:  Matthew F Lazenka; F Gerard Moeller; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.157

5.  Electroconvulsive therapy: a novel hypothesis for the involvement of purinergic signalling.

Authors:  Ahmed-Ramadan Sadek; Gillian E Knight; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-06-22       Impact factor: 3.765

6.  Cardiovascular and Subjective Effects of the Novel Adenosine A(2A) Receptor Antagonist SYN115 in Cocaine Dependent Individuals.

Authors:  Sd Lane; Ce Green; Jl Steinberg; L Ma; Jm Schmitz; N Rathnayaka; Sd Bandak; S Ferre; Fg Moeller
Journal:  J Addict Res Ther       Date:  2012-03-28

7.  Wheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptors.

Authors:  Peter J Clark; Parsa R Ghasem; Agnieszka Mika; Heidi E Day; Jonathan J Herrera; Benjamin N Greenwood; Monika Fleshner
Journal:  Behav Brain Res       Date:  2014-07-11       Impact factor: 3.332

8.  Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.

Authors:  Marco Orrú; Xavier Guitart; Marzena Karcz-Kubicha; Marcello Solinas; Zuzana Justinova; Sandeep Kumar Barodia; Janaina Zanoveli; Antoni Cortes; Carme Lluis; Vicent Casado; F Gerard Moeller; Sergi Ferré
Journal:  Neuropharmacology       Date:  2012-12-19       Impact factor: 5.250

Review 9.  The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation.

Authors:  John D Salamone; Mercè Correa; Sarah Ferrigno; Jen-Hau Yang; Renee A Rotolo; Rose E Presby
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

10.  Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences.

Authors:  Patrick A Randall; Marta Pardo; Eric J Nunes; Laura López Cruz; V Kiran Vemuri; Alex Makriyannis; Younis Baqi; Christa E Müller; Mercè Correa; John D Salamone
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.